‘Zemiglo’ license lawsuit meets new phase with Sanofi’s marketing data

At a lawsuit between LG Life Sciences and Sanofi-Aventis over close of the Zemiglo’s license, it seems a new phase is going to be developed as Sanofi turned in data about its marketing activity.

The Civil Affairs Department 17 at the Seoul Central District Court had the 5^th defense for the claim for damage filed by Sanofi-Aventis against LG Life Sciences and Daewoong Pharmaceutical at the room...